![Kristen Oberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kristen Oberg
Oficial de Cumplimiento en Mycovia Pharmaceuticals, Inc. .
Cargos activos de Kristen Oberg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Mycovia Pharmaceuticals, Inc.
![]() Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Oficial de Cumplimiento | - | - |
Consejero General | - | - |
Historial de carrera de Kristen Oberg
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Compliance Officer | 1 |
General Counsel | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Mycovia Pharmaceuticals, Inc.
![]() Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Kristen Oberg
- Experiencia